Preservation of reproductive cells (precautionary measure and donation)
Anyone may have their reproductive cells or their ovarian or testicular tissue preserved. Sperm cells made available for insemination are also preserved. The following charts show how frequently this occurs.
Sperm cells and oocytes, but also ovarian and testicular tissue, can be frozen in liquid nitrogen. Cryopreservation is used, for example, to store donor sperm. However, it can also be used in cases where fertility may be affected by medical treatment, such as chemotherapy. Irrespective of medical treatment, some women may wish to preserve oocytes in order to extend their fertility.
Number of women with precautionary preservation of oocytes or ovarian tissue
Number of men with precautionary preservation of sperm or testicular tissue
Number of men from whom donor sperm was stored on the reference date
Further information
Index
Further topics
Assisted reproductive techniques
How many couples make use of insemination? At what age do women decide to pursue in vitro fertilisation (IVF)? What types of genetic test are conducted on embryos? Data can be found here.
Handling of embryos from in vitro fertilisation
With in vitro fertilisation (IVF), embryos are produced outside the body. The charts below show how many embryos are produced in Switzerland and what types of genetic testing are performed.
Pregnancy and birth after in vitro fertilisation
How successful are IVF treatments? The charts on this page show the success rates for IVF and the numbers of premature or multiple births occurring after IVF.
Reproductive Medicine Act effectiveness review
The Federal Office of Public Health has been commissioned to review the effectiveness of the Reproductive Medicine Act (RMA). The aim of the review is to investigate whether the Act is being implemented effectively and appropriately and whether it is achieving its objectives.
Reproductive medicine
Some 3,200 couples embark on an assisted reproductive treatment every year in Switzerland. Assisted reproductive techniques are evolving rapidly and raise complex ethical and legal questions.
Federal Office of Public Health FOPH
Biosafety, Human Genetics and Reproductive Medicine Section
Schwarzenburgstrasse 157
Switzerland - 3003 Bern